产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
imiloxan | I611041-25mg | Moligand™ | 81167-16-0 | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
imiglitazar | I611040-5mg | Moligand™ | 250601-04-8 | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |
imiglitazar | I611040-25mg | Moligand™ | 250601-04-8 | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
imexon | I611039-5mg | Moligand™ | 59643-91-3 | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |
imexon | I611039-25mg | Moligand™ | 59643-91-3 | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
imetit | I611038-5mg | Moligand™ | 102203-18-9 | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |
imetit | I611038-25mg | Moligand™ | 102203-18-9 | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
imbutamine | I611037-5mg | Moligand™ | 40546-47-2 | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |
imbutamine | I611037-25mg | Moligand™ | 40546-47-2 | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
IMB-808 | I611036-5mg | Moligand™ | N/A | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |
IMB-808 | I611036-25mg | Moligand™ | N/A | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
ilunocitinib | I611035-5mg | Moligand™ | 1187594-14-4 | 5mg | ¥ 3099.9 | 期货,请咨询 | 阿拉丁 |
ilunocitinib | I611035-25mg | Moligand™ | 1187594-14-4 | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
ilorasertib | I611034-5mg | Moligand™ | 1227939-82-3 | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |
ilorasertib | I611034-25mg | Moligand™ | 1227939-82-3 | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
illudalic acid | I611033-5mg | Moligand™ | N/A | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |
illudalic acid | I611033-25mg | Moligand™ | N/A | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
ilginatinib | I611032-5mg | Moligand™ | N/A | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |
ilginatinib | I611032-25mg | Moligand™ | N/A | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
ilacirnon | I611017-5mg | Moligand™ | 1100318-47-5 | 5mg | ¥ 1624.9 | 期货,请咨询 | 阿拉丁 |
ilacirnon | I611017-25mg | Moligand™ | 1100318-47-5 | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
Il-94 | I611016-5mg | Moligand™ | N/A | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |
Il-94 | I611016-25mg | Moligand™ | N/A | 25mg | ¥ 5999.9 | 期货,请咨询 | 阿拉丁 |
IKs124 | I610973-5mg | Moligand™ | N/A | 5mg | ¥ 3999.9 | 期货,请咨询 | 阿拉丁 |